Kate Rochlin
President & Chief Operating Officer IN8Bio
Seminars
Wednesday 24th June 2026
Unlocking Gamma-Delta T Cells: A Next-Generation TCE for Safer Target Elimination in Oncology & Autoimmunity
2:30 pm
- Selective Targeting of Rare but Potent Effectors: How to precisely recruit powerful γδ T cells to drive efficient target cell elimination while sparing broader T-cell activation
- Overcoming Scarcity Through Intelligent Engineering: Unlocking the full power of γδ TCEs by novel mechanisms to expand and activate both Vδ1 and Vδ2 subsets directly in vivo
- From Oncology to Autoimmunity: A Paradigm Shift: Navigating lower risk tolerance, enabling safer target elimination, and achieving deep immune reset in autoimmune disease
